- Home
- NAN vs AMRN Comparison
NAN vs AMRN Comparison
Compare NAN & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAN | AMRN |
|---|---|---|
| Founded | 1999 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.4M | 342.8M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | NAN | AMRN |
|---|---|---|
| Price | $11.56 | $13.61 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 64.0K | ★ 82.2K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $10.79 | $12.96 |
| 52 Week High | $11.80 | $20.90 |
Technical Indicators
Market Signals| Indicator | NAN | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 29.12 |
| Support Level | $11.36 | $13.58 |
| Resistance Level | $11.60 | $17.04 |
| Average True Range (ATR) | 0.06 | 0.57 |
| MACD | -0.02 | -0.25 |
| Stochastic Oscillator | 0.00 | 2.15 |
Price Performance
Historical ComparisonAbout NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.